Long an R&D company that partnered off assets, RNAi biotech Ionis Pharmaceuticals shifted in 2025 to bring two medicines to market alone. Analysts are already impressed—and there’s more to come in ...
Alnylam Pharmaceuticals achieved profitability for the first time in its history in 2025. | Alnylam achieved profitability for the first time in its history in 2025. But disappointing sales ...
In a recent study, researchers manipulated cellular proteins that control genes in aged mice. Experimental results showed their livers were rejuvenated to younger states. This work shows promise as a ...
One of the greatest mysteries of our planet is how a soup of lifeless chemicals transformed into the first living cell. There are several competing theories about where this happened, from frozen ...
The potentially $4.4 billion deal is Madrigal’s second with a China-based biotech and hands the company six preclinical RNA ...
New Scientist on MSN
RNA strand that can almost self-replicate may be key to life's origins
Life may have begun when RNA molecules began to replicate themselves, and now we’ve finally found an RNA molecule that is very close to being able to do this ...
Scientists in the laboratory of Rendong Yang, Ph.D., associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more ...
A newly revealed “aging cliff” in sperm RNA marks a conserved molecular transition from youth to later life, offering fresh insight into how a father’s age may influence the earliest stages of ...
News-Medical.Net on MSN
Study explores how reversible RNA editing could transform future cardiovascular medicine
By Hugo Francisco de Souza Emerging research suggests reversible RNA editing mechanisms may influence heart disease biology while opening new avenues for biomarkers and next-generation cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results